A5052233022- Ultrasound in Clinical Applications
- Atrial Fibrillation Management and Outcomes
- Airway Management and Intubation Techniques
- Acute Ischemic Stroke Management
- Antimicrobial Resistance in Staphylococcus
- Emergency and Acute Care Studies
- Appendicitis Diagnosis and Management
- Cardiac Arrest and Resuscitation
- Streptococcal Infections and Treatments
- Bacterial Identification and Susceptibility Testing
- Anesthesia and Sedative Agents
- Venous Thromboembolism Diagnosis and Management
- Heart Failure Treatment and Management
- Pharmaceutical Practices and Patient Outcomes
- Urinary Tract Infections Management
- Intracerebral and Subarachnoid Hemorrhage Research
- Intestinal and Peritoneal Adhesions
- Hemodynamic Monitoring and Therapy
- Radiology practices and education
- Potassium and Related Disorders
- Cerebral Venous Sinus Thrombosis
- Cardiac electrophysiology and arrhythmias
- Innovations in Medical Education
- Respiratory Support and Mechanisms
- Sepsis Diagnosis and Treatment
Rush University Medical Center
2016-2025
Advocate Christ Medical Center
2017
Advocate Children's Hospital
2017
Loyola University Medical Center
2017
Atrium Health Wake Forest Baptist
2017
Background: Since the approval of oral factor Xa inhibitors, there have been concerns regarding ability to neutralize their anticoagulant effects after intracranial hemorrhage (ICH). Multiple guidelines suggest using prothrombin complex concentrates (PCCs) in these patients on basis research that includes a limited number with ICH. Given this, we aimed evaluate safety and efficacy PCCs for inhibitor–related ICH large, multicenter cohort patients. Methods: This was multicenter, retrospective,...
Alcohol withdrawal syndrome (AWS) is a common condition prompting emergency department (ED) presentation. However, there are limited recent, large-scale, robust data available on the incidence, admission, and medical treatment of AWS in ED. This was retrospective cohort study ED presentations for from January 1, 2016, to December 31, 2023, using Epic Cosmos. All visits with ICD-10 codes corresponding were included. Outcomes included percentage total visits, admitted, length stay (LOS),...
To determine the effectiveness and safety of andexanet prothrombin complex concentrates (PCCs) when administered after intracranial hemorrhage (ICrH) associated with direct oral anticoagulants, specifically apixaban or rivaroxaban. A multicenter, retrospective, observational study patients rivaroxaban-related ICrH who received PCCs between January 1, 2015, March 31, 2023. predefined sensitivity analysis excluding an admission Glasgow Coma Scale score less than 7 was also performed. Forty-two...
Study Objective To compare the safety and efficacy of 5 units versus 10 insulin for treatment hyperkalemia in patients with renal insufficiency. Design Retrospective cohort study. Setting Large academic medical center emergency department. Patients Between March 1, 2008, February 29, 2016, 675 met inclusion criteria age 18 years older, serum potassium greater than mEq/L, insufficiency, or intravenous regular administered department, blood glucose documented within hours after administration....
Background Allogeneic hematopoietic stem cell transplant patients are at risk of invasive fungal infections and prophylaxis with azole agents is common practice. The concomitant use these sirolimus tacrolimus for the prevention graft-versus-host disease may result in excessive immunosuppression or toxicity. Methods This retrospective study identified hospitalized who underwent allogeneic transplantation between August 2009 April 2011 Rush University Medical Center. From this group,...
Background Historically, intravenous (IV) bisphosphonates with calcitonin are the treatment of choice for hypercalcemia malignancy. However, evidence is lacking. Objective The objective this study was to compare use bisphosphonate versus moderate severe Methods This a retrospective evaluating patients who received and/or Patients usual care plus either (1) or (2) calcitonin. primary outcome change in corrected serum calcium concentrations 48 hours after treatment. Secondary outcomes included...